Abstract
We present, to our knowledge, the second case report of a 46-year old female who developed varicella-zoster virus (VZV) meningitis after BNT162b2 mRNA COVID-19 vaccination. The patient is immunocompetent and has no known predisposing risk factors for developing VZV meningitis. The patient received acyclovir therapy and subsequently had a complete recovery. We describe possible mechanisms of VZV meningitis after mRNA COVID-19 vaccination.
Keywords: BNT162b2 mRNA; COVID-19; COVID-19 vaccination; SARS-CoV-2; Varicella-zoster virus.
All Keywords
【저자키워드】 COVID-19, SARS-CoV-2, COVID-19 vaccination, BNT162b2 mRNA, Varicella-zoster virus., 【초록키워드】 therapy, Risk factors, knowledge, risk factor, virus, Case report, BNT162b2, COVID-19 vaccination, mRNA, female, Patient, Meningitis, acyclovir, mechanism, BNT162b2 mRNA, complete recovery, Varicella-Zoster Virus, varicella, 【제목키워드】 report,
【저자키워드】 COVID-19, SARS-CoV-2, COVID-19 vaccination, BNT162b2 mRNA, Varicella-zoster virus., 【초록키워드】 therapy, Risk factors, knowledge, risk factor, virus, Case report, BNT162b2, COVID-19 vaccination, mRNA, female, Patient, Meningitis, acyclovir, mechanism, BNT162b2 mRNA, complete recovery, Varicella-Zoster Virus, varicella, 【제목키워드】 report,
{{{ 추상적인 }}}
우리가 아는 한, BNT162b2 mRNA COVID-19 백신 접종 후 수두 대상포진 바이러스(VZV) 수막염이 발병한 46세 여성의 두 번째 사례 보고를 제시합니다. 환자는 면역 능력이 있으며 VZV 뇌수막염 발병에 대한 알려진 소인 위험 인자가 없습니다. 환자는 acyclovir 치료를 받은 후 완전히 회복되었습니다. 우리는 mRNA COVID-19 백신 접종 후 VZV 뇌막염의 가능한 메커니즘을 설명합니다.
{{ 키워드: }} BNT162b2 mRNA; 코로나바이러스감염증-19 : 코로나19; 코로나19 예방접종; 사스 코로나바이러스 2; 수두 대상포진 바이러스.